Colgate-Palmolive Company (CL) Insider Trading

Last 12 months

Insiders sold $57.1M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chairman, President & CEO Noel R. Wallace sold $29.7M on Aug 5, 41% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2007.

Net open-market

−$57.1M

0 buys · 13 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 8

executives and directors

Last open-market buy

Aug 2007

Aug 1, 2007

Get an email when CL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 24	Panagiotis Tsourapas COO, CD, EMEA, APac, Skin	SoldNo plan	10,000	$92.05	$921k	11%	Form 4
Aug 6	John T Cahill Director	SoldNo plan	4,170	$93.37	$389k	6.1%	Form 4
Aug 4 – 5	Noel R. Wallace Chairman, President & CEO	SoldNo plan 2 parts	322,042	$92.22 average	$29.7M	41%	Form 4
May 15	Gregory Malcolm EVP and Controller	SoldNo plan	2,300	$88.44	$203k	9.4%	Form 4
May 7	Sally Massey Chief People Officer	SoldNo plan	8,599	$87.41	$752k	28%	Form 4
Feb 11 – 12	Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin	SoldNo plan 2 parts	50,000	$95.57 average	$4.78M	40%	Form 4
Feb 10	John Hazlin Chief Growth Officer	SoldNo plan	20,989	$94.25	$1.98M	48%	Form 4
Feb 6	Gregory Malcolm EVP and Controller	SoldNo plan	12,747	$94.91	$1.21M	38%	Form 4
Feb 5	Sally Massey Chief Human Resources Officer	SoldNo plan	15,851	$95.03	$1.51M	42%	Form 4
Feb 4	Stanley J Sutula III Chief Financial Officer	SoldNo plan	97,843	$94.27	$9.22M	64%	Form 4
Feb 4	Jennifer Daniels CLO and Secretary	SoldNo plan	22,000	$94.34	$2.08M	22%	Form 4
Feb 4	Noel R. Wallace Chairman, President & CEO	SoldNo plan	45,568	$93.91	$4.28M	10%	Form 4
Nov 21, 2025	Sally Massey Chief Human Resources Officer	SoldNo plan	1,237	$80.89	$100k	5.4%	Form 4
May 15, 2025	Sally Massey Chief Human Resources Officer	SoldNo plan	2,250	$88.97	$200k	9.9%	Form 4
Feb 25, 2025	Sally Massey Chief Human Resources Officer	SoldNo plan	8,000	$92.02	$736k	26%	Form 4
Nov 26, 2024	Gregory Malcolm EVP and Controller	SoldNo plan	1,054	$95.94	$101k	6.0%	Form 4
Nov 22, 2024	Noel R. Wallace Chairman, President & CEO	Sold10b5-1 plan	33,333	$95.00	$3.17M	8.2%	Form 4
Nov 5, 2024	Stanley J Sutula III Chief Financial Officer	SoldNo plan	45,410	$94.11	$4.27M	55%	Form 4
Nov 4, 2024	Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts	SoldNo plan	20,032	$93.30	$1.87M	25%	Form 4
Nov 1, 2024	Stanley J Sutula III Chief Financial Officer	SoldNo plan	50,000	$93.53	$4.68M	57%	Form 4

Aug 24No plan
Panagiotis Tsourapas
COO, CD, EMEA, APac, Skin · sold 10,000 at $92.05
$921k
11% of stake
Aug 6No plan
John T Cahill
Director · sold 4,170 at $93.37
$389k
6.1% of stake
Aug 4 – 5No plan
Noel R. Wallace
Chairman, President & CEO · sold 322,042 at avg $92.22
$29.7M
41% of stake
May 15No plan
Gregory Malcolm
EVP and Controller · sold 2,300 at $88.44
$203k
9.4% of stake
May 7No plan
Sally Massey
Chief People Officer · sold 8,599 at $87.41
$752k
28% of stake
Feb 11 – 12No plan
Panagiotis Tsourapas
COO, Eur., APac, Afr Eur, Skin · sold 50,000 at avg $95.57
$4.78M
40% of stake
Feb 10No plan
John Hazlin
Chief Growth Officer · sold 20,989 at $94.25
$1.98M
48% of stake
Feb 6No plan
Gregory Malcolm
EVP and Controller · sold 12,747 at $94.91
$1.21M
38% of stake
Feb 5No plan
Sally Massey
Chief Human Resources Officer · sold 15,851 at $95.03
$1.51M
42% of stake
Feb 4No plan
Stanley J Sutula III
Chief Financial Officer · sold 97,843 at $94.27
$9.22M
64% of stake
Feb 4No plan
Jennifer Daniels
CLO and Secretary · sold 22,000 at $94.34
$2.08M
22% of stake
Feb 4No plan
Noel R. Wallace
Chairman, President & CEO · sold 45,568 at $93.91
$4.28M
10% of stake
Nov 21, 2025No plan
Sally Massey
Chief Human Resources Officer · sold 1,237 at $80.89
$100k
5.4% of stake
May 15, 2025No plan
Sally Massey
Chief Human Resources Officer · sold 2,250 at $88.97
$200k
9.9% of stake
Feb 25, 2025No plan
Sally Massey
Chief Human Resources Officer · sold 8,000 at $92.02
$736k
26% of stake
Nov 26, 2024No plan
Gregory Malcolm
EVP and Controller · sold 1,054 at $95.94
$101k
6.0% of stake
Nov 22, 202410b5-1 plan
Noel R. Wallace
Chairman, President & CEO · sold 33,333 at $95.00
$3.17M
8.2% of stake
Nov 5, 2024No plan
Stanley J Sutula III
Chief Financial Officer · sold 45,410 at $94.11
$4.27M
55% of stake
Nov 4, 2024No plan
Panagiotis Tsourapas
Grp Pres, Eur& Developing Mkts · sold 20,032 at $93.30
$1.87M
25% of stake
Nov 1, 2024No plan
Stanley J Sutula III
Chief Financial Officer · sold 50,000 at $93.53
$4.68M
57% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Perfumes, Cosmetics & Other Toilet Preparations

KVUEKenvue Inc.

ELThe Estée Lauder Companies Inc.

COTYCoty Inc.

EPCEdgewell Personal Care Co.

ECLEcolab Inc.

CLXThe Clorox Company

CHDChurch & Dwight Co., Inc.

SCLStepan Company

Spot a number that looks wrong? Check it in CL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.